Table of Content



1 Introduction
1.1. What is this report about?
1.2. Who is the target reader?
1.3. How to use this report
1.4. Definitions

2 Group of Eight (G8) Generics
2.1. Industry Outlook

3 Generics in Canada
3.1. Market Overview
3.2. Market Data
3.3. Market Segmentation
3.4. Market outlook
3.5. Five forces analysis
3.6. Macroeconomic Indicators

4 Generics in France
4.1. Market Overview
4.2. Market Data
4.3. Market Segmentation
4.4. Market outlook
4.5. Five forces analysis
4.6. Macroeconomic Indicators

5 Generics in Germany
5.1. Market Overview
5.2. Market Data
5.3. Market Segmentation
5.4. Market outlook
5.5. Five forces analysis
5.6. Macroeconomic Indicators

6 Generics in Italy
6.1. Market Overview
6.2. Market Data
6.3. Market Segmentation
6.4. Market outlook
6.5. Five forces analysis
6.6. Macroeconomic Indicators

7 Generics in Japan
7.1. Market Overview
7.2. Market Data
7.3. Market Segmentation
7.4. Market outlook
7.5. Five forces analysis
7.6. Macroeconomic Indicators

8 Generics in Russia
8.1. Market Overview
8.2. Market Data
8.3. Market Segmentation
8.4. Market outlook
8.5. Five forces analysis
8.6. Macroeconomic Indicators

9 Generics in The United Kingdom
9.1. Market Overview
9.2. Market Data
9.3. Market Segmentation
9.4. Market outlook
9.5. Five forces analysis
9.6. Macroeconomic Indicators

10 Generics in The United States
10.1. Market Overview
10.2. Market Data
10.3. Market Segmentation
10.4. Market outlook
10.5. Five forces analysis
10.6. Macroeconomic Indicators

11 Company Profiles
11.1. Pfizer Inc.
11.2. Teva Pharmaceutical Industries Limited
11.3. Apotex, Inc.
11.4. Mylan N.V.
11.5. Les Laboratoires Servier
11.6. Sanofi SA
11.7. STADA Arzneimittel AG
11.8. Daiichi Sankyo Co Ltd
11.9. Sawai Pharmaceutical Co Ltd
11.10. Lupin Ltd
11.11. Krka, d. d., Novo mesto
11.12. Abbott Laboratories

12 Appendix
12.1. Methodology
12.2. About MarketLine



List of Figures


Figure 1: G8 generics industry, revenue($m), 2015-2
Figure 2: G8 Generics industry, revenue by country (%), 2019
Figure 3: G8 generics industry, revenue by country ($m), 2015-19
Figure 4: G8 generics industry forecast, revenue by country ($m), 2019-24
Figure 5: Canada generics market value: $ million, 2015–19
Figure 6: Canada generics market volume: % of total pharma, 2015–19
Figure 7: Canada generics market geography segmentation: % share, by value, 2019
Figure 8: Canada generics market value forecast: $ million, 2019–24
Figure 9: Canada generics market volume forecast: % of total pharma, 2019–24
Figure 10: Forces driving competition in the generics market in Canada, 2019
Figure 11: Drivers of buyer power in the generics market in Canada, 2019
Figure 12: Drivers of supplier power in the generics market in Canada, 2019
Figure 13: Factors influencing the likelihood of new entrants in the generics market in Canada, 2019
Figure 14: Factors influencing the threat of substitutes in the generics market in Canada, 2019
Figure 15: Drivers of degree of rivalry in the generics market in Canada, 2019
Figure 16: France generics market value: $ million, 2015–19
Figure 17: France generics market volume: % of total pharma, 2015–19
Figure 18: France generics market geography segmentation: % share, by value, 2019
Figure 19: France generics market value forecast: $ million, 2019–24
Figure 20: France generics market volume forecast: % of total pharma, 2019–24
Figure 21: Forces driving competition in the generics market in France, 2019
Figure 22: Drivers of buyer power in the generics market in France, 2019
Figure 23: Drivers of supplier power in the generics market in France, 2019
Figure 24: Factors influencing the likelihood of new entrants in the generics market in France, 2019
Figure 25: Factors influencing the threat of substitutes in the generics market in France, 2019
Figure 26: Drivers of degree of rivalry in the generics market in France, 2019
Figure 27: Germany generics market value: $ billion, 2015–19
Figure 28: Germany generics market volume: % of total pharma, 2015–19
Figure 29: Germany generics market geography segmentation: % share, by value, 2019
Figure 30: Germany generics market value forecast: $ billion, 2019–24
Figure 31: Germany generics market volume forecast: % of total pharma, 2019–24
Figure 32: Forces driving competition in the generics market in Germany, 2019
Figure 33: Drivers of buyer power in the generics market in Germany, 2019
Figure 34: Drivers of supplier power in the generics market in Germany, 2019
Figure 35: Factors influencing the likelihood of new entrants in the generics market in Germany, 2019
Figure 36: Factors influencing the threat of substitutes in the generics market in Germany, 2019
Figure 37: Drivers of degree of rivalry in the generics market in Germany, 2019
Figure 38: Italy generics market value: $ million, 2015–19
Figure 39: Italy generics market volume: % of total pharma, 2015–19
Figure 40: Italy generics market geography segmentation: % share, by value, 2019
Figure 41: Italy generics market value forecast: $ million, 2019–24
Figure 42: Italy generics market volume forecast: % of total pharma, 2019–24
Figure 43: Forces driving competition in the generics market in Italy, 2019
Figure 44: Drivers of buyer power in the generics market in Italy, 2019
Figure 45: Drivers of supplier power in the generics market in Italy, 2019
Figure 46: Factors influencing the likelihood of new entrants in the generics market in Italy, 2019
Figure 47: Factors influencing the threat of substitutes in the generics market in Italy, 2019
Figure 48: Drivers of degree of rivalry in the generics market in Italy, 2019
Figure 49: Japan generics market value: $ billion, 2015–19
Figure 50: Japan generics market volume: % of total pharma, 2015–19


List of Tables


Table 1: G8 generics industry, revenue($m), 2015-24
Table 2: G8 generics industry, revenue by country ($m), 2015-19
Table 3: G8 generics industry forecast, revenue by country ($m), 2019-24
Table 4: Canada generics market value: $ million, 2015–19
Table 5: Canada generics market volume: % of total pharma, 2015–19
Table 6: Canada generics market geography segmentation: $ million, 2019
Table 7: Canada generics market value forecast: $ million, 2019–24
Table 8: Canada generics market volume forecast: % of total pharma, 2019–24
Table 9: Canada size of population (million), 2015–19
Table 10: Canada gdp (constant 2005 prices, $ billion), 2015–19
Table 11: Canada gdp (current prices, $ billion), 2015–19
Table 12: Canada inflation, 2015–19
Table 13: Canada consumer price index (absolute), 2015–19
Table 14: Canada exchange rate, 2015–19
Table 15: France generics market value: $ million, 2015–19
Table 16: France generics market volume: % of total pharma, 2015–19
Table 17: France generics market geography segmentation: $ million, 2019
Table 18: France generics market value forecast: $ million, 2019–24
Table 19: France generics market volume forecast: % of total pharma, 2019–24
Table 20: France size of population (million), 2015–19
Table 21: France gdp (constant 2005 prices, $ billion), 2015–19
Table 22: France gdp (current prices, $ billion), 2015–19
Table 23: France inflation, 2015–19
Table 24: France consumer price index (absolute), 2015–19
Table 25: France exchange rate, 2015–19
Table 26: Germany generics market value: $ billion, 2015–19
Table 27: Germany generics market volume: % of total pharma, 2015–19
Table 28: Germany generics market geography segmentation: $ billion, 2019
Table 29: Germany generics market value forecast: $ billion, 2019–24
Table 30: Germany generics market volume forecast: % of total pharma, 2019–24
Table 31: Germany size of population (million), 2015–19
Table 32: Germany gdp (constant 2005 prices, $ billion), 2015–19
Table 33: Germany gdp (current prices, $ billion), 2015–19
Table 34: Germany inflation, 2015–19
Table 35: Germany consumer price index (absolute), 2015–19
Table 36: Germany exchange rate, 2015–19
Table 37: Italy generics market value: $ million, 2015–19
Table 38: Italy generics market volume: % of total pharma, 2015–19
Table 39: Italy generics market geography segmentation: $ million, 2019
Table 40: Italy generics market value forecast: $ million, 2019–24
Table 41: Italy generics market volume forecast: % of total pharma, 2019–24
Table 42: Italy size of population (million), 2015–19
Table 43: Italy gdp (constant 2005 prices, $ billion), 2015–19
Table 44: Italy gdp (current prices, $ billion), 2015–19
Table 45: Italy inflation, 2015–19
Table 46: Italy consumer price index (absolute), 2015–19
Table 47: Italy exchange rate, 2015–19
Table 48: Japan generics market value: $ billion, 2015–19
Table 49: Japan generics market volume: % of total pharma, 2015–19
Table 50: Japan generics market geography segmentation: $ billion, 2019